To investigate the therapeutic potential of APα to delay or reverse myelination deficits that occur in human AD [24], [25] and in 3xTgAD mice, we investigated the impact of APα on myelin expression in 3xTgAD mouse brain. Here, ENPEP is linked to Alzheimer disease.